Redeye updates on Maximum Entertainment following Q4-results which saw softer topline than expected ...
A leading education provider growing faster than peers Solid visibility—90% of academic year revenue...
Redeye is encouraged by Systemair’s strong top-line, including 5% organic growth in the third quarte...
Safello has announced it intends to launch of exchange-traded products (ETPs), a pivotal step to div...
Systemair överraskar med en stark organisk tillväxt på 5,4 procent under det tredje kvartalet, övert...
CirChem (”CirChem” eller ”Bolaget”) har nyligen stängt böckerna för Q4-24 och kan summera ett år prä...
Redeye comments on Kancera’s announcement of a letter of intent with Recardio Inc.
Q4: DKK 155m SDR impairment, adj. EBIT slightly better vs.
Redeye endorses Ortoma’s received CE certification for OTS Hip Guide in accordance with MDR.
Redeye provides a comment on Freemelt’s new order from Saab.
Kinda Brave Entertainment Group AB (”Kinda Brave” eller ”Koncernen”) meddelade den 5 mars år 2025 at...
Redeye comments on the announcement of a SEK34.1m rights issue of shares.
IRLAB Therapeutics has announced top-line results from the Phase IIb REACT-PD study evaluating its s...
Neovici AB (”Neovici” eller ”Bolaget”) är ett snabbväxande SaaS-bolag inom fintech som har utvecklat...
Cantargia has reported encouraging pharmacokinetic data from the first cohort in the multiple ascend...
Guiding for higher organic growth and margin expansion in 2025e Acquisition of Sounding Board should...
Redeye notes that Systemair continues to show healthy top-line growth in its third quarter of 2024/2...
Q4 profit was below forecast but the declared dividend was above.
Alzecure får god draghjälp av European Innovation Council och kan fortsätta planeringen av en fas 2a...
Gabather AB (“Gabather” or “the Company”) is advancing GT-002, a first-in-class GABAA-modulator, thr...
